ResearcherUniversité Paris CitéActive in the last 2 years
Tatiana Codjia
Matched on ORCID iD 0000-0002-8601-204X; OpenAlex author ID A5027217614. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2024: 1 paper · 2025: none · 2026: 3 papers
Papers 4
- Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative… Co-author DOI 10.1245/s10434-026-19545-w↗
- ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Inj… Co-author DOI 10.1245/s10434-026-19641-x↗
- ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver … Co-author DOI 10.1245/s10434-026-19683-1↗
- Distal Pancreatectomy for Body Pancreatic Ductal Adenocarcinoma: Is Splenectomy Necessary? A Propensity Score Matched Study. Co-author DOI 10.1245/s10434-024-15220-0↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alain Sauvanet · 4 shared papers, 2024–2026 · strength 1.04
- Paper Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-A… DOI 10.1245/s10434-026-19545-w↗
- Paper ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Featu… DOI 10.1245/s10434-026-19641-x↗
- Paper ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Fe… DOI 10.1245/s10434-026-19683-1↗
- Farha Tessier · 3 shared papers, 2026 · strength 0.84
- Paper Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-A… DOI 10.1245/s10434-026-19545-w↗
- Paper ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Featu… DOI 10.1245/s10434-026-19641-x↗
- Paper ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Fe… DOI 10.1245/s10434-026-19683-1↗
- Jules Grégory · 3 shared papers, 2026 · strength 0.84
- Paper Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-A… DOI 10.1245/s10434-026-19545-w↗
- Paper ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Featu… DOI 10.1245/s10434-026-19641-x↗
- Paper ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Fe… DOI 10.1245/s10434-026-19683-1↗
- Maxime Ronot · 3 shared papers, 2026 · strength 0.84
- Paper Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-A… DOI 10.1245/s10434-026-19545-w↗
- Paper ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Featu… DOI 10.1245/s10434-026-19641-x↗
- Paper ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Fe… DOI 10.1245/s10434-026-19683-1↗
- Safi Dokmak · 1 shared paper, 2024 · strength 0.20
- Jerome F. Cros · 1 shared paper, 2024 · strength 0.20
- Christian Hobeika · 1 shared paper, 2024 · strength 0.20
- Mickaël Lesurtel · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.